Contact this trialFirst, we need to learn more about you.
Radioligand Therapy
Lu-PSMA-617 for Liver Cancer
Recruiting1 awardPhase 2
Cleveland, Ohio
This trial aims to see how a drug called 177Lu-PSMA-617 affects individuals with liver cancer that has a specific marker called PSMA.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service